RecruitingNCT06336239

PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study

Sponsor

Beijing Anzhen Hospital

Enrollment

3,000 participants

Start Date

Dec 21, 2023

Study Type

OBSERVATIONAL

Conditions

Cardiovascular Disease Type 2 Diabetes Mellitus

Summary

The association between Cardiovascular Disease (CVD) and Chronic Kidney Disease (CKD) is well established. Traditional risk factors for CVD and CKD are similar, with type 2 diabetes mellitus (T2DM) being the most prevalent risk factor. However, CKD is underdiagnosed and undertreated in patients with CVD. Further understanding of the combination of CKD in CVD patients is important to formulate prevention and treatment strategies for CVD patients and high-risk groups, reduce adverse events in CVD patients, and prevent progression of CKD to End Stage Renal Disease (ESRD).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is measuring how common abnormal kidney function (detected by a protein called albumin in the urine) is in patients who have both type 2 diabetes and cardiovascular disease. This combination puts people at high risk for kidney damage, which often goes undetected until it's advanced. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with type 2 diabetes AND at least one cardiovascular condition (such as high blood pressure, coronary artery disease, atrial fibrillation, or heart failure) - You are being seen at a cardiology clinic at a participating center **You may NOT be eligible if...** - You are pregnant or breastfeeding - You are on dialysis - You have another serious cause of elevated urine albumin (such as confirmed kidney disease unrelated to diabetes) - You have active cancer being treated - You have severe liver disease or cachexia (severe weight loss from illness) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(27)

Beijing Sixth Hospital

Beijing, Beijing Municipality, China

Fangshan District First Hospital

Beijing, Beijing Municipality, China

Peking University Third Hospital

Beijing, Beijing Municipality, China

Chinese PLA Army Characteristic Medical Center

Chongqing, Chongqing Municipality, China

Haidong City Second People's Hospital

Haidong, Gansu, China

The First Affiliated Hospital of Sun Yat-sen University

Guangzhou, Guangdong, China

First Hospital of Hebei Medical University

Shijiazhuang, Hebei, China

Ruyang County People's Hospita

Luoyang, Henan, China

Luoyang Sixth People's Hospita

Luoyang, Henan, China

Yongcheng People's Hospital

Yongcheng, Henan, China

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China

Zhangjiagang Sixth People's Hospital

Zhangjiagang, Jiangsu, China

Shenyang Ninth People's Hospital

Shenyang, Liaoning, China

Shenyang Tenth People's Hospital

Shenyang, Liaoning, China

Jining First People's Hospital

Jining, Shandong, China

Tai'an First People's Hospital

Tai’an, Shandong, China

Weihai Central Hospital

Weihai, Shandong, China

Jing'an District Central Hospital of Shanghai

Shanghai, Shanghai Municipality, China

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China

Zhongshan Hospital Fudan University Qingpu Branch

Shanghai, Shanghai Municipality, China

Qinyuan County People's Hospital

Changzhi, Shanxi, China

Shanxi Bethune Hospital

Taiyuan, Shanxi, China

The First Affiliated Hospital of Xi'an Jiaotong University

XI Ail, Shanxi, China

The Fifth People's Hospital of Sichuan Province

Chengdu, Sichuan, China

West China Hospital of Sichuan University

Chengdu, Sichuan, China

The First Affiliated Hospital of Xinjiang Medical University

Ürümqi, Xinjiang, China

Taizhou Central Hospital

Taizhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06336239

Related Trials

Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention

NCT019277831 location

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

NCT07136012243 locations

POLUS: Description of the Effectiveness and Tolerability of Luseogliflozin in Patients With Type 2 Diabetes.

NCT074331921 location

Awareness of Risk Factors and Perception of Cardiovascular Risk in Secondary Prevention Among Women and Men

NCT075214361 location

Williams Syndrome (WS) and Supravalvar Aortic Stenosis (SVAS) DNA and Tissue Bank

NCT027066393 locations